BMY

7 Stocks Primed for a Spectacular Comeback in 2024

By Josh Enomoto, InvestorPlace Contributor
While investors might be tempted to ride the biggest winners of last year, shifting sands may provide a superior outlook for comeback stocks. Just what…

Why Is RayzeBio (RYZB) Stock Up 100% Today?

By Dana Blankenhorn, InvestorPlace Contributor
RYZB stock has doubled today after Bristol Myers Squibb shelled out $4.1 billion to buy RayzeBio. Expect more such deals in 2024.

3 Potential Turnaround Stocks to Buy for Big Rewards in 2024

By Ian Cooper, InvestorPlace Contributor
There was plenty to get excited about in 2023 and even more to get excited about with turnaround stocks in the new year.

7 Stocks with Strong Insider Buying: December 2023

By Chris Markoch, InvestorPlace Contributor
Stocks with strong insider buying should make you curious, and finding them can be a useful shortcut for your research

Why Is Avidity Biosciences (RNA) Stock Up 15% Today?

By Larry Ramer, InvestorPlace Contributor
RNA stock is jumping over 15% in early trading after Avidity announced its expanded alliance with Bristol-Myers Squibb.

3 Resilient Stocks with Massive Potential to Boost Your Wealth

By Rich Duprey, InvestorPlace Contributor
These three stocks with massive potential can make patient investors fabuslously wealthy as they come roaring back to life.

Soothing Stocks: 7 Reliable Picks to Ease Your Market Jitters

By Josh Enomoto, InvestorPlace Contributor
Based on the strong print of the major indices since late last month, the idea of deliberately targeting reliable stocks for a volatile market might…

Why Is Bristol-Myers Squibb (BMY) Stock Down Today?

By William White, InvestorPlace Writer
Bristol-Myers Squibb stock is falling on Monday as investors in BMY shares react to two updates weighing on the company's stock.

Debt-Fueled Buybacks: 3 Stocks Undeterred by Rising Rates

By Will Ashworth, InvestorPlace Contributor
Share repurchases have slowed in 2023, partly due to the 1% tax. Here are three buybacks partially paid for with debt offerings.

Why Is LianBio (LIAN) Stock Up 130% Today?

By Josh Enomoto, InvestorPlace Contributor
With LianBio inking a key exclusive licensing agreement with Bristol-Myers Squibb, LIAN stock is jumping up on the credibility implications.

7 Healthcare Stocks That Can Cure a Lackluster Portfolio

By Joel Baglole, InvestorPlace Contributor
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio.

7 Innovator Stocks Primed for Exceptional Growth

By Chandler Capital, InvestorPlace Contributor
As the market continues to rebound, investors should keep an eye on these companies at the forefront of innovation. They stand poised to surge ahead of their competition in terms of revenue and earnings.

Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs

By Larry Ramer, InvestorPlace Contributor
CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T.

Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024

By Joel Baglole, InvestorPlace Contributor
However, pharmaceutical stocks can be expected to eventually rebound. The good news for investors is that many pharma stocks are on sale right now and can be purchased at rock bottom prices.

Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.

By Alex Sirois, InvestorPlace Contributor
These three healthcare stocks to sell are waving red flags at investors who should pay attention or suffer the consequences.

The 3 Best Pharma Stocks to Buy Now: September 2023

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
There are pharma stocks to buy for each type of investor. This article explores the best options in the industry.

Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries

By Larry Ramer, InvestorPlace Contributor
Long-term investors looking for biotech stocks well-positioned to be lifted by major discoveries should pick firms that utilize AI. 

3 Sorry Pharma Stocks to Sell in August Before It’s Too Late

By Tyrik Torres, InvestorPlace Contributor
Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell.

Looking for a Bargain? 7 Blue-Chip Stocks to Buy That Are Down 5% in 2023

By Muslim Farooque, InvestorPlace Contributor
These discounted blue-chip stocks boast robust underlying businesses which present amazing long-term upside potential ahead
Load More